top of page
Remibrutinib Convergence Advisory Summit
The 34th International Symposium on ALS/MND
The 34th International Symposium on ALS/MND
Phase 3b Extension Study Evaluating Superiority of Daily vs Approved On/Off Oral Edaravone Dosing in Patients With Amyotrophic Lateral Sclerosis
Direct Download
bottom of page
